Five months after giving up on its lead drug Betalutin for follicular lymphoma, Nordic Nanovector has charted a course forward via a merger with fellow Norwegian biotech APIM Therapeutics. The merger ...

- Financing will be used to further develop APIM Therapeutics lead anti-cancer compound towards late preclinical development. APIM Therapeutics, a preclinical biotech company focusing on the ...

SAN MATEO, Calif.--(BUSINESS WIRE)--SnapLogic, the leader in generative integration, today announced the launch of its next-generation API management (APIM) solution, helping organizations accelerate ...